National Research Corporation $NRC Shares Acquired by QV Investors Inc.

QV Investors Inc. lifted its position in shares of National Research Corporation (NASDAQ:NRC) by 7.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 381,310 shares of the company’s stock after purchasing an additional 26,950 shares during the period. QV Investors Inc. owned about 1.67% of National Research worth $6,406,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Strs Ohio acquired a new stake in National Research in the first quarter valued at $33,000. Aviso Financial Inc. raised its holdings in National Research by 37.2% in the first quarter. Aviso Financial Inc. now owns 3,076 shares of the company’s stock valued at $39,000 after acquiring an additional 834 shares in the last quarter. Signaturefd LLC raised its holdings in National Research by 31.4% in the second quarter. Signaturefd LLC now owns 4,531 shares of the company’s stock valued at $76,000 after acquiring an additional 1,084 shares in the last quarter. CWM LLC raised its holdings in National Research by 192.0% in the second quarter. CWM LLC now owns 6,847 shares of the company’s stock valued at $115,000 after acquiring an additional 4,502 shares in the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new stake in National Research in the first quarter valued at $118,000. 47.26% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of National Research in a report on Tuesday, October 14th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, National Research presently has an average rating of “Sell”.

National Research Price Performance

Shares of NASDAQ:NRC opened at $11.66 on Friday. The stock has a market capitalization of $268.88 million, a price-to-earnings ratio of 15.34 and a beta of 0.41. National Research Corporation has a 1-year low of $9.76 and a 1-year high of $21.64. The company’s fifty day moving average is $13.94 and its two-hundred day moving average is $14.05. The company has a debt-to-equity ratio of 3.61, a quick ratio of 0.70 and a current ratio of 0.70.

National Research (NASDAQ:NRC) last issued its earnings results on Monday, July 28th. The company reported $0.28 earnings per share for the quarter. The company had revenue of $34.04 million for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.